Patient's whole genome reveals risk of diseases and adverse drug responses
Thursday, April 29, 2010 - 18:10
in Health & Medicine
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patient's full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.